Janux Therapeutics, Inc. Shares Outstanding (Cover Page)
Janux Therapeutics, Inc. (JANX) had Shares Outstanding (Cover Page) of 61.14 million shares as of 2026-08-04, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-04: Entity Common Stock, Shares Outstanding 61.14M shares.
- 2026-05-05: Entity Common Stock, Shares Outstanding 60.98M shares.
- 2026-02-24: Entity Common Stock, Shares Outstanding 60.83M shares.
- 2025-11-04: Entity Common Stock, Shares Outstanding 60.15M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-04 | 61.14M shares 10-Q · filed 2026-08-06 |
| 2026-05-05 | 60.98M shares 10-Q · filed 2026-05-07 |
| 2026-02-24 | 60.83M shares 10-K · filed 2026-02-26 |
| 2025-11-04 | 60.15M shares 10-Q · filed 2025-11-06 |
| 2025-08-05 | 60.09M shares 10-Q · filed 2025-08-07 |
| 2025-05-06 | 59.18M shares 10-Q · filed 2025-05-08 |
| 2025-02-25 | 59.11M shares 10-K · filed 2025-02-27 |
| 2024-11-04 | 52.48M shares 10-Q · filed 2024-11-06 |
| 2024-08-05 | 52.16M shares 10-Q · filed 2024-08-07 |
| 2024-05-03 | 51.85M shares 10-Q · filed 2024-05-08 |
| 2024-03-06 | 51.66M shares 10-K · filed 2024-03-08 |
| 2023-11-03 | 46.17M shares 10-Q · filed 2023-11-07 |
| 2023-08-04 | 46.14M shares 10-Q · filed 2023-08-08 |
| 2023-05-05 | 41.83M shares 10-Q · filed 2023-05-09 |
| 2023-03-08 | 41.83M shares 10-K · filed 2023-03-10 |
| 2022-11-04 | 41.66M shares 10-Q · filed 2022-11-10 |
| 2022-08-05 | 41.66M shares 10-Q · filed 2022-08-09 |
| 2022-05-06 | 41.63M shares 10-Q · filed 2022-05-10 |
| 2022-03-16 | 41.62M shares 10-K · filed 2022-03-18 |
| 2021-11-05 | 41.61M shares 10-Q · filed 2021-11-09 |
| 2021-08-06 | 41.61M shares 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |